| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Co-Diagnostics Inc (NASDAQ: CODX)
CODX Technical Analysis
5
| As on 9th Jun 2023 CODX STOCK Price closed @ 1.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.34 & Strong Sell for SHORT-TERM with Stoploss of 7.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CODXSTOCK Price
| Open | 1.10 | Change | Price | % |
| High | 1.12 | 1 Day | -0.03 | -2.80 |
| Low | 1.02 | 1 Week | -0.05 | -4.59 |
| Close | 1.04 | 1 Month | -0.28 | -21.21 |
| Volume | 113000 | 1 Year | -8.00 | -88.50 |
| 52 Week High 10.37 | 52 Week Low 1.04 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CODX Daily Charts |
CODX Intraday Charts |
Whats New @ Bazaartrend |
CODX Free Analysis |
|
|
CODX Important Levels Intraday
| RESISTANCE | 1.23 |
| RESISTANCE | 1.17 |
| RESISTANCE | 1.13 |
| RESISTANCE | 1.09 |
| SUPPORT | 0.99 |
| SUPPORT | 0.95 |
| SUPPORT | 0.91 |
| SUPPORT | 0.85 |
CODX Forecast May 2024
| 4th UP Forecast | 7.9 |
| 3rd UP Forecast | 5.7 |
| 2nd UP Forecast | 4.34 |
| 1st UP Forecast | 2.98 |
| 1st DOWN Forecast | -0.9 |
| 2nd DOWN Forecast | -2.26 |
| 3rd DOWN Forecast | -3.62 |
| 4th DOWN Forecast | -5.82 |
CODX Weekly Forecast
| 4th UP Forecast | 5.14 |
| 3rd UP Forecast | 3.83 |
| 2nd UP Forecast | 3.01 |
| 1st UP Forecast | 2.20 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -0.93 |
| 3rd DOWN Forecast | -1.75 |
| 4th DOWN Forecast | -3.06 |
CODX Forecast2024
| 4th UP Forecast | 20.16 |
| 3rd UP Forecast | 14.03 |
| 2nd UP Forecast | 10.24 |
| 1st UP Forecast | 6.45 |
| 1st DOWN Forecast | -4.37 |
| 2nd DOWN Forecast | -8.16 |
| 3rd DOWN Forecast | -11.95 |
| 4th DOWN Forecast | -18.08 |
Co-Diagnostics Inc ( NASDAQ USA Symbol : CODX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CODX Business Profile
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Address: 2401 South Foothill Drive, Salt Lake City, UT, United States, 84109
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service